Hamadi Madhi, PhD

Education

Bioindustrial Engineering diploma, University of Carthage, Tunisia
MSc in Molecular biology (Cancer biology), Gyeongsang National University, South Korea
PhD in Medical Science (Cancer biology), Yonsei University, South Korea

Research Interests

Cancer resistance
Immunotherapy
Cancer stem cells
Drug screening
Single-cell sequencing

Hobbies

Collecting stamps, traveling, kayaking and wine and cheese tasting

Contact

Recent Publications

Madhi H, Lee JS, Choi YE, Li Y, Kim MH, Choi Y, Goh SH. FOXM1 Inhibition Enhances the Therapeutic Outcome of Lung Cancer Immunotherapy by Modulating PD-L1 Expression and Cell Proliferation. Adv Sci (Weinh). 2022 Oct;9(29):e2202702.

Madhi H, Kim MH. Beyond X-Chromosome Inactivation: The Oncogenic Facet of XIST in Human Cancers. Biomedical Science Letters 2019, 25(2): 113~122 eISSN : 2288-7415.

Choi YE, Madhi H, Kim H, Lee JS, Kim MH, Kim YN, Goh SH. FAM188B Expression Is Critical for Cell Growth via FOXM1 Regulation in Lung Cancer. Biomedicines. 2020 Oct 31;8(11):465. PMID: 33142744; PMCID: PMC7693245.

Oh SS, Lee KW, Madhi H, Jeong JW, Park S, Kim M, Lee Y, Han HT, Hwangbo C, Yoo J, Kim KD. Cordycepin resensitizes T24R2 Cisplatin-Resistant Human Bladder Cancer Cells to Cisplatin by Inactivating Ets-1 Dependent MDR1 Transcription. Int J Mol Sci. 2020 Mar 2;21(5):1710. PMID: 32131547; PMCID: PMC7084876.